|
| |
Articles
1-192 out of 192 article(s)
| Title |
Author |
Type |
Date |
Words |
| Sihuan's First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration. |
|
|
May 25, 2012 |
691 |
| Research and Markets: Peptic Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2018. |
|
|
May 21, 2012 |
558 |
| PA32540 Provides Faster Gastric Acid Reduction Than Enteric-Coated Omeprazole (40 mg). |
|
|
May 19, 2012 |
1128 |
| Pernix Therapeutics Reports First Quarter 2012 Financial Results. |
|
|
May 15, 2012 |
7268 |
| Pernix Therapeutics Introduces Omeclamox-Pak, First Product in Gastroenterology Portfolio. |
|
|
May 15, 2012 |
877 |
| "The efficacy of endoscopic therapy in bleeding peptic ulcer patients. |
Levin, Dion A.; Watermeyer, Gillian A.; Deetlefs, Eduan; Metz, David C.; Thomson, Sandie R. |
Report |
May 1, 2012 |
3149 |
| Limit aspirin for CVD, cancer prevention to 55-75 set. |
London, Susan |
|
Mar 15, 2012 |
786 |
| FDA: C. difficile diarrhea can be linked to PPIs. |
Brunk, Doug |
|
Mar 1, 2012 |
361 |
| Community-associated Clostridium difficile infections, Monroe County, New York, USA. |
Dumyati, Ghinwa; Stevens, Vanessa; Hannett, George E.; Thompson, Angela D.; Long, Cherie; MacCannell |
|
Mar 1, 2012 |
6368 |
| Identification of phthalates in medications and dietary supplement formulations in the United States and Canada. |
Kelley, Katherine E.; Hernandez-Diaz, Sonia; Chaplin, Erica L.; Hauser, Russ; Mitchell, Allen A. |
Report |
Mar 1, 2012 |
6056 |
| FDA warns: PPIs can be associated with C. difficile diarrhea. |
Brunk, Doug |
|
Mar 1, 2012 |
339 |
| POST-MENOPAUSAL women who take common [...]. |
|
|
Feb 6, 2012 |
245 |
| Behind-the-counter statins: a silver bullet for reducing costs and increasing access? |
Sood, Neeraj; Sun, Eric; Zhuo, Xiaohui |
Report |
Feb 1, 2012 |
4992 |
| Gastritis and gastropathy: more than meets the eye: this paper discusses the different types of gastritides and gastropathies, focusing on their wide range of aetiologies. |
Nel, Willie |
|
Feb 1, 2012 |
2786 |
| Clopidogrel pharmacogenetics in the clinic. |
Levy |
|
Feb 1, 2012 |
1017 |
| Acid reflux drug does not improve asthma symptoms in kids. |
|
|
Jan 25, 2012 |
379 |
| Role of sucralfate in promoting healing of post band variceal ulcer. |
Sakr, Mohamed Amin; Hamed, Waleed Abd El-Atty; El Gafaary, Maha Mohammad; El-Folly, Runia Fouad; El- |
Report |
Dec 31, 2011 |
5194 |
| Klaire Labs' fifth annual Probiotic Symposium highlights putting probiotics into practice. |
|
Conference news |
Dec 1, 2011 |
2040 |
| Gilead Receives European Marketing Authorization for Eviplera[R], a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naove Adults. |
|
|
Nov 28, 2011 |
1666 |
| GERD management update. |
Golden, William E.; Hopkins, Robert H. |
Clinical report |
Nov 1, 2011 |
856 |
| Companiesandmarkets.com: GERD market impacted by patent expirations. |
|
|
Oct 19, 2011 |
448 |
| Gastroesophageal Reflux Disease (GERD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. |
|
|
Oct 17, 2011 |
2522 |
| On World Arthritis Day, AstraZeneca Encourages Greater Awareness, Education of Osteoarthritis. |
|
|
Oct 12, 2011 |
2074 |
| Omental transplantation for peripheral vascular disease-our experience. |
Pai, Ashwin; Bhat, Sriram; Ram, H.S. Shankar; Pai, Sheila R.; Pai, Shobha G. |
Clinical report |
Oct 1, 2011 |
3524 |
| Helicobacter pylori infection: a review of current scientific research on the efficacy or potential of herbal medicine for the treatment of H. pylori infection of the gastric mucosa. |
Williams, Lee |
Report |
Sep 22, 2011 |
5465 |
| Drug-induced urticaria: causes and clinical courses. |
Rutnin, Ni-on; Kulthanan, Kanokvalai; Tuchinda, Papapit; Jongiarearnprasert, Kowit |
Clinical report |
Sep 1, 2011 |
3475 |
| Trainers awarded wins; IN BRIEF. |
|
|
Aug 15, 2011 |
126 |
| U.S. Food and Drug Administration Approves Gilead Sciences' Complera[TM], a New Complete Once-Daily, Single-Tablet Regimen for HIV-1 Infection in Treatment-Naove Adults. |
|
|
Aug 10, 2011 |
3656 |
| Literature review & commentary. |
Gaby, Alan R. |
|
Aug 1, 2011 |
2090 |
| POZEN Reports Second Quarter 2011 Results. |
|
|
Jul 28, 2011 |
6309 |
| EDURANT(TM) 96-Week Phase 3 Safety and Efficacy Data Presented at International AIDS Society Conference. |
|
Conference news |
Jul 19, 2011 |
1857 |
| Peptic ulcers heal in aspirin users on PPIs. |
Wendling, Patrice |
Clinical report |
Jun 15, 2011 |
523 |
| FDA Approves NEXIUM[R] I.V. (Esomeprazole Sodium) for the Treatment of Gastroesophageal Reflux Disease (GERD) with Erosive Esophagitis in Pediatric and Adolescent Patients. |
|
|
May 2, 2011 |
1104 |
| Mayo Clinic Health Letter, March 2011 Highlights: Getting Rid of Ulcer Pain; Sound Wave Imaging for the Diagnosis of Liver Fibrosis; Telomeres Hint at Benefits of Healthy Living. |
|
|
Mar 8, 2011 |
1046 |
| An ethnomedicinal survey conducted amongst folk medicinal practitioners in the two southern districts of Noakhali and Feni, Bangladesh. |
Rahmatullah, Mohammed; Abdullah-Al-Mahmud; Rahman, Atikur; Uddin, Farhan; Hasan, Mehedi; Khatun, Afs |
Report |
Mar 1, 2011 |
9633 |
| Prebiotics and probiotics/Pre ve probiyotikler. |
Kutlu, Tufan |
Report |
Mar 1, 2011 |
4433 |
| Merck's ISENTRESS[R] (raltegravir) Demonstrated Durable Reductions in HIV-1 Viral Load and Sustained Tolerability At Three Years of Treatment in Previously Untreated Adult Patients Infected with HIV-1. |
|
Drug overview |
Mar 1, 2011 |
31078 |
| Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX[R]. |
|
|
Jan 25, 2011 |
1497 |
| Ray Joseph's notebook: observations on the mysteries of peptic ulcers. |
|
|
Dec 22, 2010 |
1165 |
| Follow-Up Results from Study Comparing SPRYCEL[R] (dasatinib) to Imatinib in First-Line Treatment of Adults with Ph+ CP-CML Demonstrate Improved Response Rates Consistent with 12 Month Data. |
|
|
Dec 6, 2010 |
2685 |
| PPIs might raise risk of cardiac birth defects. |
Splete, Heidi |
|
Dec 1, 2010 |
528 |
| Merck Reports Initial Results of Phase III Study of ISENTRESS[R] (raltegravir) Investigational Once-Daily Dosing in Treatment-Naove Adult Patients Infected with HIV-1. |
|
Drug overview |
Nov 29, 2010 |
24347 |
| Apricus Biosciences Files Phase 3 Registration Protocol for PrevOnco[TM] for Special Protocol Assessment Consideration by the FDA. |
|
|
Nov 22, 2010 |
796 |
| Adding PPI to dual antiplatelets cuts GI bleeds. |
Moon, Mary Ann |
|
Nov 1, 2010 |
582 |
| FDA Approves SPRYCEL[R] (dasatinib) as Treatment for Adult Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia in Chronic Phase. |
|
|
Oct 28, 2010 |
2811 |
| Anti-ulcer & antioxidant activities of Hedranthera barteri {(Hook F.) Pichon} with possible involvement of [H.sup.+], [K.sup.+] ATPase inhibitory activity. |
Onasanwo, Samuel A.; Singh, Neetu; Olaleye, Samuel B.; Mishra, Vaibhav; Palit, Gautam |
Report |
Oct 1, 2010 |
4900 |
| SMC Issues Positive Recommendation on esomeprazole 10mg (Nexium(R)) For Children Aged one to 11 Years old in Scotland With Gastro-Oesophageal Reflux Disease (GORD). |
|
|
Sep 13, 2010 |
921 |
| FDA releases latest list of drugs being examined for safety issues. |
|
Brief article |
Sep 7, 2010 |
229 |
| Trends in hospitalizations for peptic ulcer disease, United States, 1998-2005. |
Feinstein, Lydia B.; Holman, Robert C.; Christensen, Krista L. Yorita; Steiner, Claudia A.; Swerdlow |
|
Sep 1, 2010 |
6492 |
| Eye irritations, late heat cycles: plus, a puzzling case of muscle pain. |
Holcomb, Tom |
|
Aug 31, 2010 |
1332 |
| Osteo-myocutanoeus flap: a novel flap for single toe amputation. |
Sciberras, Nadia; Murphy, Jamie; Wilson, Alan |
Case study |
Aug 1, 2010 |
906 |
| Vitamin C enhances Helicobacter pylori eradication. |
Gaby, Alan R. |
Brief article |
Jul 1, 2010 |
209 |
| PPI use, fracture risk tied to other risk factors. |
Napoli, Denise |
|
Jul 1, 2010 |
853 |
| FDA warns on fracture risks with PPIs. |
Ault, Alicia |
|
Jul 1, 2010 |
251 |
| Hybrid therapy for H. pylori achieved superior eradication. |
Helwick, Caroline |
|
Jul 1, 2010 |
549 |
| Merck to Initiate Proof-of-Concept Study of Posaconazole for Chronic Chagas Disease, Recognized by WHO as One of the World's Neglected Tropical Diseases. |
|
Drug overview |
Jun 24, 2010 |
8655 |
| Bactericidal action of mastic gum on H. pylori. |
Finney-Brown, Tessa |
Report |
Jun 22, 2010 |
478 |
| Global Peptic Ulcer Testing industry. |
|
|
Jun 16, 2010 |
2351 |
| PPIs get fracture risk warning. |
|
|
Jun 15, 2010 |
122 |
| PPIs can cause 'addiction' to acid suppression. |
Helwick, Caroline |
Clinical report |
Jun 15, 2010 |
826 |
| Horizon Pharma Announces LODOTRA(R) and DUEXA(R) Data to be Presented at the European League Against Rheumatism (EULAR) Annual Congress. |
|
|
Jun 9, 2010 |
1311 |
| FDA Roundup: Aurobindo Pharma Ltd. |
|
|
Jun 7, 2010 |
489 |
| Chabal facing disqualification after sample. |
|
|
May 22, 2010 |
188 |
| Reportlinker Adds Global Peptic Ulcer Testing industry. |
|
|
May 17, 2010 |
2404 |
| Data Presented at DDW About Rebound Symptoms in Healed Erosive Esophagitis Patients After Completion of Treatment with DEXILANT(TM) (dexlansoprazole). |
|
|
May 5, 2010 |
1018 |
| The overlooked compound that saves lives. |
Goepp, Julius |
Report |
May 1, 2010 |
3247 |
| NexMed Files Investigational New Drug Application with FDA for Cancer Drug Candidate. |
|
|
Mar 29, 2010 |
891 |
| Anticoagulants plus acid-suppressive agents: an unsafe combination? |
|
|
Mar 22, 2010 |
335 |
| Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to PLAVIX U.S. Prescribing Information. |
|
|
Mar 12, 2010 |
1555 |
| The effect of mastic gum on Helicobacter pylori: a randomized pilot study. |
Dabos, K.J.; Sfika, E.; Vlatta, L.J.; Giannikopoulos, G. |
Report |
Mar 1, 2010 |
2901 |
| Proton pump inhibitor suppression of calcium absorption presenting as respiratory distress in a patient with bilateral laryngeal paralysis and hypocalcemia. |
Zaya, Ninef E.; Woodson, Gayle |
Clinical report |
Feb 1, 2010 |
1687 |
| Cranberry one berry and a whole body of health benefits. |
|
|
Jan 1, 2010 |
2536 |
| Post-PCI cardiac risk up with clopidogrel + PPI. |
Boschert, Sherry |
Clinical report |
Jan 1, 2010 |
298 |
| Are you getting enough vitamin B12? |
Singh, Bina |
Report |
Jan 1, 2010 |
2531 |
| Refractory gastro-oesophageal reflux disease: a major management issue in clinical practice: refractory gastro-oesophageal reflux disease can be frustrating, for both patient and practitioner. |
Van Rensburg, Christo |
Disease/Disorder overview |
Jan 1, 2010 |
2886 |
| A case of eosinophilic ulcer localized at lower lip/Alt dudakta yerlesen bir eozinofilik ulser olgusu. |
Yetkin, Hicran; Basak, Pinar Yuksel; Akkaya, Vahide Baysal; Inan, Gulsun; Kapucuoglu, Nilgun |
Report |
Dec 1, 2009 |
1555 |
| Santarus Reports Third Quarter 2009 Financial Results. |
|
Financial report |
Nov 4, 2009 |
2352 |
| Buruli ulcer in United Kingdom tourist returning from Latin America. |
McGann, Hugh; Stragier, Pieter; Portaels, Francoise; Gascoyne-Binzi, Deborah; Collyns, Timothy; Luca |
Clinical report |
Nov 1, 2009 |
1637 |
| Results of Phase I Study Show Novel, Investigational PA65020 Compound Significantly Decreased Risk of Upper GI Damage in Healthy Adults. |
|
|
Oct 27, 2009 |
899 |
| Mastic through the ages. |
Gordin, Karina L. |
Report |
Oct 1, 2009 |
2506 |
| Life on the edge: the clinical implications of gastrointestinal biofilm. |
Olmstead, Stephen; Meiss, Dennis; Ralston, Janet |
Report |
Oct 1, 2009 |
4476 |
| Eisai Submits Application for Additional Indication of its Proton Pump Inhibitor PARIET(R) for Non-erosive GERD in Japan. |
|
|
Sep 29, 2009 |
425 |
| An ethnobotanical survey and pharmacological evaluation of medicinal plants used by the Garo tribal community living in Netrakona district, Bangladesh. |
Rahmatullah, Mohammed; Mukti, Israt Jahan; Haque, A.K.M. Fahmidul; Mollik, Md. Ariful Haque; Parvin, |
Report |
Sep 1, 2009 |
11322 |
| Sucampo Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gastrointestinal Injuries. |
|
Clinical report |
Jul 1, 2009 |
1291 |
| Elusive victory a landmark for sire; French Guineas heroine shows progeny do train on. |
|
|
May 12, 2009 |
1476 |
| Study validates gastric anti-ulcer properties of herb medicine Rocket 'Eruca sativa'. |
|
|
May 9, 2009 |
271 |
| Common heartburn drugs may reduce anti-clotting medications' benefits. |
|
|
May 7, 2009 |
502 |
| Restrictions on business relationships with industries, and their unintended adverse consequences. |
Sataloff, Robert T. |
|
May 1, 2009 |
2422 |
| Refractory gastro-oesophageal reflux disease can be frustrating, for both patient and practitioner. (Refractory gastro-oesophageal reflux disease: a major management issue in clinical practice. |
van Rensburg, Christo |
Report |
May 1, 2009 |
2628 |
| Gastric cancer is a common form of cancer which generally has a poor prognosis. |
Fritz, Elongo Lekunze; van der Merwe, Schalk Willem |
Disease/Disorder overview |
May 1, 2009 |
2619 |
| Ulcer drugs with ibuprofen may offer Alzheimer's treatment. |
|
|
Apr 23, 2009 |
289 |
| Heartburn drugs may not help asthma sufferers. |
|
|
Apr 21, 2009 |
408 |
| Santarus Announces FDA Acceptance of New Drug Application for ZEGERID Tablet Product. |
|
|
Apr 6, 2009 |
1208 |
| Soon, anti-ulcer yoghurt. |
|
|
Mar 23, 2009 |
321 |
| Emerging therapy-related kidney disease. |
Arend, Lois J.; Nadasdy, Tibor |
Report |
Feb 1, 2009 |
7465 |
| Sucampo Completes Enrollment in Its Phase 2 Trial of Cobiprostone for the Prevention of NSAID-Induced Ulcers. |
|
|
Jan 8, 2009 |
1032 |
| Meda: First Combination of NSAID and Proton Pump Inhibitor Approved. |
|
|
Dec 9, 2008 |
322 |
| This natural solution to acid reflux is safer and less expensive than antacids. |
|
Clinical report |
Dec 1, 2008 |
1300 |
| Profile of non traumatic surgical disorders found in the pilgrims/ trekkers travelling to Shri Amarnath Ji cave. |
Mir, I.S.; Mir, M.; Ahmed, M. |
Report |
Dec 1, 2008 |
2436 |
| Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice. |
Nilforoushzadeh, M.A.; Shirani-Bidabadi, L.; Zolfaghari-Baghbaderani, A.; Saberi, S.; Siadat, A.H.; |
Report |
Dec 1, 2008 |
2742 |
| Santarus Reports Third Quarter 2008 Financial Results. |
|
Financial report |
Nov 3, 2008 |
2512 |
| New foci of Buruli ulcer, Angola and Democratic Republic of Congo. |
Kibadi, Kapay; Panda, Mbutu; Tamfum, Jean-Jacques Muyembe; Fraga, Alexandra G.; Filho, Adhemar Longa |
|
Nov 1, 2008 |
2084 |
| Takeda Pharmaceutical Co. |
|
Brief article |
Oct 27, 2008 |
146 |
| Johnson loses Sedgefield appeal. |
|
|
Sep 19, 2008 |
260 |
| POZEN To Present at The UBS Life Sciences Conference. |
|
Conference news |
Sep 10, 2008 |
219 |
| POZEN Sponsors Habitat for Humanity Home in Hillsborough, North Carolina. |
|
|
Sep 8, 2008 |
438 |
| POZEN To Present at the 3rd Annual Citi Biotech Day. |
|
|
Aug 26, 2008 |
201 |
| vital: Ulcers not diet related. |
|
|
Aug 25, 2008 |
350 |
| POZEN Receives Initial FDA Response To PA32540 SPA. |
|
|
Aug 1, 2008 |
680 |
| POZEN Reports Second Quarter 2008 Results. |
|
|
Jul 29, 2008 |
1142 |
| POZEN to Present at the 2008 BMO Capital Markets Focus on Healthcare Conference. |
|
Conference news |
Jul 24, 2008 |
220 |
| POZEN Announces July 29, 2008 Webcast of Second Quarter 2008 Results. |
|
|
Jul 15, 2008 |
242 |
| Low Levels of Diagnosis and New Biological Approaches to Treatment Indicate a Positive Future for Gastrointestinal Drugs. |
|
|
Jun 18, 2008 |
788 |
| POZEN To Present at the Jefferies 2nd Annual Healthcare Conference. |
|
Conference news |
Jun 16, 2008 |
212 |
| POZEN Demonstrates Bioequivalence to Enteric Coated Aspirin for PA32540. |
|
|
Jun 9, 2008 |
747 |
| POZEN To Present at the Seventh Annual Needham & Co., LLC Biotechnology & Medical Technology Conference. |
|
Conference news |
Jun 2, 2008 |
203 |
| POZEN Announces PN 200 Podium Presentation at Digestive Disease Week. |
|
|
May 19, 2008 |
856 |
| POZEN To Present at the Citigroup Global Healthcare Conference. |
|
Conference news |
May 15, 2008 |
202 |
| POZEN IND and NDA for Treximet(TM) (Sumatriptan/Naproxen Sodium) Transferred to GlaxoSmithKline. |
|
|
May 14, 2008 |
561 |
| POZEN Reports First Quarter 2008 Results. |
|
Financial report |
May 8, 2008 |
1056 |
| POZEN To Present at Baird's 2008 Growth Stock Conference. |
|
Conference news |
May 1, 2008 |
204 |
| POZEN Announces Receipt of $20 Million in Milestone Payments from GlaxoSmithKline. |
|
|
Apr 28, 2008 |
824 |
| POZEN Announces May 8, 2008 Webcast of First Quarter 2008 Results. |
|
|
Apr 25, 2008 |
248 |
| Get the Most Health for Your Pharmacy Dollars. |
|
|
Apr 22, 2008 |
1002 |
| OrCel[R] in the treatment of venous ulcers. |
Heller, Marissa |
Brief article |
May 1, 2007 |
128 |
| Antiulcerogenic potential of Strychnos potatorum Linn seeds on aspirin plus pyloric ligation-induced ulcers in experimental rats. |
Sanmugapriya, E.; Venkataraman, S. |
Clinical report |
May 1, 2007 |
3335 |
| Breath analysis: potential for clinical diagnosis and exposure assessment. |
Cao, Wenqing; Duan, Yixiang |
|
May 1, 2006 |
10831 |
| Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. |
Mini, Roberta; Annibale, Bruno; Lahner, Edith; Bernardini, Giulia; Figura, Natale; Santucci, Annalis |
|
Feb 1, 2006 |
4952 |
| Effects of water extract of Usnea longissima on antioxidant enzyme activity and mucosal damage caused by indomethacin in rats. |
Halici, M.; Odabasoglu, F.; Suleyman, H.; Cakir, A.; Aslan, A.; Bayir, Y. |
|
Sep 1, 2005 |
4884 |
| Pharmacological assay of Cordia verbenacea V: oral and topical anti-inflammatory activity, analgesic effect and fetus toxicity of a crude leaf extract. |
Sertie, J.A.A.; Woisky, R.G.; Wiezel, G.; Rodrigues, M. |
|
May 1, 2005 |
4071 |
| Anti-ulcer and anti-oxidant activity of Pepticare, a herbomineral formulation. |
Bafna, P.A.; Balaraman, R. |
|
Apr 1, 2005 |
5170 |
| Antiulcerogenic activity of a crude hydroalcoholic extract and coumarin isolated from Mikania laevigata Schultz Bip. |
Bighetti, A.E.; Antonio, M.A.; Kohn, L.K.; Rehder, V.L.G.; Foglio, M.A.; Possenti, A.; Vilela, L.; C |
|
Jan 1, 2005 |
4296 |
| For second-trimester abortion, women given misoprostol vaginally report the greatest satisfaction. |
Hollander, D. |
|
May 1, 2004 |
733 |
| In vitro evaluation of Bacopa monniera on anti-Helicobacter pylori activity and accumulation of prostaglandins. |
Goel, R.K.; Sairam, K.; Babu, M. Dora; Tavares, I.A.; Raman, A. |
|
Jul 1, 2003 |
3388 |
| Anti-inflammatory and antiulcerogenic effects of the aqueous extract of Lobaria pulmonaria (L.) Hoffm. |
Suleyman, H.; Odabasoglu, F.; Aslan, A.; Cakir, A.; Karagoz, Y.; Gocer, F.; Halici, M.; Bayir, Y. |
|
Jul 1, 2003 |
3879 |
| Drug Update: Peptic Ulcer Disease. |
Zoler, Mitchel L.; Brunk, Doug |
|
Sep 1, 2001 |
1399 |
| Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations? |
Cromwell, David M.; Bass, Eric B.; Steinberg, Earl P.; Yasui, Yutaka; Ravich, William J.; Hendrix, T |
|
Feb 1, 1999 |
4500 |
| IntraBiotics Announces Results of Phase I Trial of Protegrin IB-367 for the Treatment of Oral Mucositis. |
|
|
Aug 27, 1998 |
565 |
| Novartis given approval by FDA to market Apligraf for the treatment of venous leg ulcers |
|
Article |
Jun 15, 1998 |
166 |
| Access Pharmaceuticals, Inc. Announces Agreement With Block Drug Company for the International Rights to Amlexanox. |
|
Article |
Jun 4, 1998 |
543 |
| Development of FlexSure[R] HP--an immunochromatographic method to detect antibodies against Helicobacter pylori. |
Schrier, Wayne H.; Schoengold, Ronald J.; Baker, Josefina T.; Norell, Joyce L.; Jaseph, Corey L.; Ok |
|
Feb 1, 1998 |
4908 |
| PREVPAC Now Available for Convenient Therapy for H. pylori Ulcers |
|
|
Jan 27, 1998 |
552 |
| Genome Therapeutics Delivers Vaccine Antigens to Astra in Helicobacter Pylori Alliance |
|
|
Oct 27, 1997 |
510 |
| Axcan Pharma Announces the Completion of its Canadian Multicentre Study for H. Pylori Eradication. |
|
|
Oct 20, 1997 |
381 |
| Geneva Pharmaceuticals, Inc., Submits Citizen Petition to the FDA |
|
|
May 22, 1997 |
357 |
| Evaluation of a rapid, new method for detecting serum IgG antibodies to Helicobacter pylori. |
Sharma, Tarun K.; Young, Eugene L.; Miller, Sherry; Cutler, Alan F. |
|
May 1, 1997 |
3726 |
| Novopharm USA's Agreement with Glaxo Wellcome Puts A Generic Version of Zantac(R) on Market More Than Two Weeks Early |
|
|
Apr 24, 1997 |
615 |
| Novavax Receives Third Patent for Helicore(TM) to Kill Helicobacter pylori Bacteria |
|
|
Apr 16, 1997 |
249 |
| Eisai and Janssen Pharmaceutica Announce Strategic Alliance for New Proton Pump Inhibitor |
|
|
Apr 15, 1997 |
375 |
| U.S. Appeals Court Clears Final Hurdle for Novopharm to Make Glaxo Wellcome's Zantac |
|
|
Apr 6, 1997 |
473 |
| OraVax, Inc. Adopts Shareholder Rights Plan |
|
|
Apr 4, 1997 |
823 |
| Neose Technologies, Inc. Receives $9.4 Million In Financing Through Montgomery County Development Authority |
|
|
Apr 2, 1997 |
685 |
| Bentley Pharmaceuticals receives approval to market new 28-capsule presentation of its ulcer product, Belmazol, in Spain. |
|
|
Feb 24, 1997 |
434 |
| Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency. |
Linder, Mark W.; Prough, Russell A.; Valdes, Roland Jr. |
|
Feb 1, 1997 |
10304 |
| P&G and QUIDEL To Promote H. pylori Duodenal Ulcer Products To Physicians |
|
|
Jan 14, 1997 |
1419 |
| P&G Begins Selling New Ulcer Drug |
|
|
Nov 25, 1996 |
1162 |
| P&G Grants Glaxo Licensing Rights To Its Ulcer Drug Technology |
|
|
Nov 25, 1996 |
253 |
| P&G Settles Patent Infringement Lawsuit On Ulcer Drug |
|
|
Oct 18, 1996 |
276 |
| MERETEK UBT Breath Test For H. Pylori Now Available to Gastroenterologists For Detecting Ulcer-Causing Bacterium |
|
|
Oct 16, 1996 |
904 |
| P&G Receives FDA Clearance For New Ulcer Drug Therapy |
|
|
Aug 22, 1996 |
945 |
| New Therapy to Cure the Cause of Most Duodenal Ulcers Receives Marketing Clearance from the U.S. Food and Drug Administration |
|
|
Aug 12, 1996 |
818 |
| U.S. Patent Issues For OraVax, Inc.'s Oral Treatment of H. pylori Infection |
|
|
Aug 5, 1996 |
699 |
| NOVOPHARM WINS RIGHT TO MAKE GLAXO WELLCOME'S ZANTAC; RULING ENDS SIX-YEAR BATTLE WITH DRUG GIANT TO MAKE GENERIC ZANTAC |
|
|
Jul 7, 1996 |
542 |
| COURT RULES IN ZANTAC PATIENT INFRINGEMENT ACTION |
|
|
Jul 7, 1996 |
394 |
| AXID AR, THE NEWEST ADVANCE IN HEARTBURN PREVENTION, CLEARED FOR OTC SALE |
|
|
May 10, 1996 |
696 |
| AXID AR, the newest advance in heartburn prevention, cleared for OTC sale. |
|
|
May 9, 1996 |
625 |
| Carrington Laboratories receives additional 510(K) approval for the Carrington(TM) patch. |
|
|
May 1, 1996 |
437 |
| FDA CLEARS FIRST COMBINATION THERAPY TO CURE CAUSE OF ULCERS |
|
|
Apr 15, 1996 |
833 |
| FIRST COMBINATION THERAPY TO CURE CAUSE OF ULCERS NOW AVAILABLE; NEW HOPE FOR ULCER PATIENTS |
|
|
Apr 15, 1996 |
287 |
| Organogenesis initiates pivotal trial on Graftskin for the treatment of Diabetic Ulcers. |
|
|
Mar 12, 1996 |
323 |
| ChemTrak files for FDA clearance of H.pylori test. |
|
|
Feb 5, 1996 |
563 |
| Cortecs enters into A$2.5 Million R&D syndication for the development of its oral Helicobacter pylori treatment. |
|
|
Jan 17, 1996 |
974 |
| FDA ADVISORY COMMITTEES RECOMMEND MARKETING APPROVAL OF BIAXIN FOR COMBINATION ULCER TREATMENT |
|
|
Dec 14, 1995 |
923 |
| ORAVAX AND PASTEUR MERIEUX-CONNAUGHT SUCCESSFULLY COMPLETE CLINICAL TRIAL OF WORLD'S FIRST ORAL VACCINE AGAINST PEPTIC ULCER DISEASE |
|
|
Dec 13, 1995 |
746 |
| FDA ADVISORY COMMITTEES RECOMMEND PRILOSEC/BIAXIN COMBINATION TO ERADICATE ULCER-CAUSING BACTERIA |
|
|
Dec 13, 1995 |
570 |
| BIOSPECIFICS TECHNOLOGIES CORP. ANNOUNCES SUCCESSFUL ITALIAN CLINICAL TRIALS |
|
|
Dec 6, 1995 |
456 |
| Is there a relationship? Esophageal cancer and ulcer medication. |
Brown, Edwin W. |
|
Dec 1, 1995 |
775 |
| SPAN-AMERICA REPORTS 47% INCREASE IN FOURTH QUARTER EARNINGS; DECLARES QUARTERLY DIVIDEND. |
|
|
Oct 30, 1995 |
662 |
| FDA COMMITTEE RECOMMENDS CHANGES IN NSAID LABELING; CALL ISSUED FOR EDUCATION, PREVENTION OF NSAID RISKS |
|
|
Oct 12, 1995 |
588 |
| P&G SEEKS FDA CLEARANCE FOR ULCER TREATMENT |
|
|
Jul 26, 1995 |
918 |
| TAP DRUG CLEARED BY FDA FOR TREATMENT OF EROSIVE ESOPHAGITIS AND DUODENAL ULCERS |
|
|
May 11, 1995 |
772 |
| ASTRA MERCK STATEMENT ON AVAILABILITY OF LANSOPRAZOLE |
|
|
May 11, 1995 |
328 |
| FDA CLEARS PEPCID(R) AC ACID CONTROLLER OTC SWITCH VERSION OF THE WIDELY PRESCRIBED RX MEDICINE |
|
|
Apr 30, 1995 |
1447 |
| APPEALS COURT UPHOLDS GLAXO'S ZANTAC PATENT |
|
|
Apr 21, 1995 |
356 |
| ZANTAC(R) (RANITIDINE HYDROCHLORIDE) INDICATED FOR MAINTENANCE OF HEALING OF GASTRIC ULCERS |
|
|
Apr 7, 1995 |
363 |
| GLAXO PROVIDES ELIGIBLE CONSUMERS SAVINGS ON ZANTAC EFFERDOSE TABLETS AND GRANULES AND ZANTAC GELDOSE CAPSULES |
|
|
Mar 6, 1995 |
535 |
| ChemTrak and Astra Merck sign agreement for H. pylori test. |
|
|
Mar 2, 1995 |
755 |
| ABBOTT SUBMITS SUPPLEMENTAL NDA FOR BIAXIN (CLARITHROMYCIN) FOR TREATMENT OF H. PYLORI INFECTION |
|
|
Dec 27, 1994 |
274 |
| MARION MERRELL DOW INC. TO CO-PROMOTE PRILOSEC(R) WITH ASTRA MERCK INC. IN THE UNITED STATES |
|
|
Nov 29, 1994 |
367 |
| FDA GRANTS NOVOPHARM ABBREVIATED NEW DRUG APPLICATION (ANDA) FOR GENERIC ZANTAC |
|
|
Nov 9, 1994 |
591 |
| PROCYTE COMPLETES ENROLLMENT FOR FIRST PHASE III PIVOTAL WOUND HEALING STUDY |
|
|
May 6, 1994 |
392 |
| MARION MERRELL DOW ANNOUNCES NEW FORMULATION OF WIDELY PRESCRIBED ANTIULCER MEDICATION |
|
|
Dec 20, 1993 |
296 |
|
